In The News,
Following the White House’s announcement on insulin cost caps in Medicare, ADVI’s Lindsay Bealor Greenleaf sat down with the American Journal of Managed Care to share her thoughts
[el-text]
Written by Allison Inserro and Mary Caffrey
***excerpt***
“The Part D Senior Savings Model addresses this disincentive for insulin by allowing manufacturers to continue paying their full coverage gap discount for their products, even when a plan offers lower cost-sharing, in exchange for requiring the participating Part D plan to lower cost-sharing to no more than $35 for a month’s supply of insulin.”
***end excerpt***
[/el-text]